Daniel O’Connell

Daniel O'Connell MD,PhD is a highly experienced professional in the biotechnology and healthcare industry. With a background in biochemistry, organic chemistry, and mathematics, Daniel has held various roles in companies such as Terremoto Biosciences, Novo Holdings, Bristol Myers Squibb, and LogicBio Therapeutics. Daniel's expertise in equity investments, partnerships, and strategic transactions has contributed to the growth and development of these organizations. Daniel's commitment to developing therapies for rare diseases and advancing breakthrough biotech companies showcases their dedication to making a positive impact in the field of life sciences.